ATE406887T1 - R-bambuterol, seine herstellung und therapeutische verwendungen - Google Patents

R-bambuterol, seine herstellung und therapeutische verwendungen

Info

Publication number
ATE406887T1
ATE406887T1 AT02807678T AT02807678T ATE406887T1 AT E406887 T1 ATE406887 T1 AT E406887T1 AT 02807678 T AT02807678 T AT 02807678T AT 02807678 T AT02807678 T AT 02807678T AT E406887 T1 ATE406887 T1 AT E406887T1
Authority
AT
Austria
Prior art keywords
bambuterol
production
therapeutic uses
enantiomer
acceptable salts
Prior art date
Application number
AT02807678T
Other languages
German (de)
English (en)
Inventor
J L Cheng
Wen Tan
Original Assignee
Wen Tan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wen Tan filed Critical Wen Tan
Application granted granted Critical
Publication of ATE406887T1 publication Critical patent/ATE406887T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT02807678T 2002-08-08 2002-08-08 R-bambuterol, seine herstellung und therapeutische verwendungen ATE406887T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/025225 WO2004014290A2 (en) 2002-08-08 2002-08-08 R-bambuterol, its preparation and therapeutic uses

Publications (1)

Publication Number Publication Date
ATE406887T1 true ATE406887T1 (de) 2008-09-15

Family

ID=31713793

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02807678T ATE406887T1 (de) 2002-08-08 2002-08-08 R-bambuterol, seine herstellung und therapeutische verwendungen

Country Status (8)

Country Link
EP (2) EP2002831A1 (enExample)
JP (1) JP4979889B2 (enExample)
CN (1) CN100356913C (enExample)
AT (1) ATE406887T1 (enExample)
AU (1) AU2002332488A1 (enExample)
DE (1) DE60228764D1 (enExample)
ES (1) ES2312669T3 (enExample)
WO (1) WO2004014290A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100803291B1 (ko) 2006-09-08 2008-02-13 (주)팜스웰 밤부테롤 염산염의 개선된 제조방법
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
CN102617404A (zh) * 2012-04-06 2012-08-01 张长利 盐酸班布特罗及其中间体的制备工艺
CN103288670B (zh) * 2013-05-16 2014-11-05 南京医科大学第一附属医院 多羟基二苯甲酮衍生物及其应用
CN104478740B (zh) * 2014-11-19 2017-01-25 上海化工研究院 一种稳定同位素标记β受体激动剂类化合物的合成方法
CN104557614B (zh) * 2014-12-15 2017-01-04 广东东阳光药业有限公司 一种胺的还原方法
CN105254512B (zh) * 2015-11-10 2017-03-22 山东达因海洋生物制药股份有限公司 一种硫酸特布他林的制备方法
CN106831452A (zh) * 2017-02-15 2017-06-13 杭州百诚医药科技股份有限公司 一种硫酸特布他林的制备方法
CN107445867A (zh) * 2017-07-13 2017-12-08 上海昕盛医药科技有限公司 一种盐酸班布特罗杂质b的合成方法
CN107445866A (zh) * 2017-07-13 2017-12-08 上海昕盛医药科技有限公司 一种盐酸班布特罗杂质d的合成方法
WO2020028124A1 (en) * 2018-07-31 2020-02-06 Wen Tan NEW USE OF CARBAMATE β PHENYLETHANOLAMINE ANALOGUES FOR ENHANCING INTRACELLULAR CLEARANCE OF LDL CHOLESTEROL AND FOR COMBINING THERAPY WITH STATINS TO ENHANCE THE EFFICACY AND REDUCE ADVERSE EFFECTS
CN109942462B (zh) * 2019-03-06 2022-01-14 宏冠生物药业有限公司 一种盐酸班布特罗的合成工艺
WO2020247136A2 (en) * 2019-05-07 2020-12-10 Wen Tan USE OF R-ENANTIOMER β2-AGONISTS FOR PREVENT AND TREATMENT OF PULMONARY INFLAMMATION AND INFLAMMATORY REMODELING FOR REDUCED ADVERSE EFFECTS
CN115531368A (zh) * 2021-06-14 2022-12-30 谭文 R-氨基甲酸酯-β-苯乙醇胺类化合物治疗学习和记忆缺陷以及神经退行性疾病的应用
CN117586152A (zh) * 2023-11-23 2024-02-23 黑龙江乌苏里江制药有限公司 一种盐酸班布特罗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) * 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE60228764D1 (de) 2008-10-16
JP4979889B2 (ja) 2012-07-18
EP1542672B1 (en) 2008-09-03
WO2004014290A3 (en) 2004-08-05
AU2002332488A1 (en) 2004-02-25
AU2002332488A8 (en) 2004-02-25
CN100356913C (zh) 2007-12-26
WO2004014290A2 (en) 2004-02-19
EP1542672A2 (en) 2005-06-22
EP2002831A1 (en) 2008-12-17
CN1638756A (zh) 2005-07-13
JP2006503816A (ja) 2006-02-02
ES2312669T3 (es) 2009-03-01
EP1542672A4 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE441635T1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
ATE294171T1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate,deren herstellung und deren therapeutische verwendung
ATE406887T1 (de) R-bambuterol, seine herstellung und therapeutische verwendungen
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ATE409184T1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
ATE325122T1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
PL374831A1 (pl) Zmodyfikowane proleki 2' i 3'-nukleozydowe do leczenia zakażeń Flaviviridae
ATE233274T1 (de) Oxyiminopregnancarbolactone
ATE469131T1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
DE60002526D1 (de) Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
ATE412635T1 (de) Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung
ATE372998T1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
NO20052420D0 (no) Farmakologisk behandling av sovnapn±.
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
NO20031648L (no) Farmasöytiske lösninger av modafinilforbindelser
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
BR0312446A (pt) 2-heteroaril carboxamidas
NO20051521L (no) Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties